Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Drug Development

      EC approves Roches Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer

      FDA Approvals
      Roche announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or...

      U.S. FDA Approves Gileads Antiviral Veklury (remdesivir) for Treatment of COVID-19

      FDA Approvals
      Gilead Sciences, Inc. announced that the U.S. FDA has approved the antiviral drug Veklury for the treatment of patients with COVID-19 requiring hospitalization. As...

      Lilly and Incyte Highlight Positive Data for Olumiant in Rheumatoid Arthritis

      Clinical Trials
      Eli Lilly and Company and Incyte announced positive data for Olumiant will be presented at ACR Convergence 2020, the American College of Rheumatology's virtual...

      Novartis sickle cell medicine Adakveo approved in Europe to prevent recurrent vaso-occlusive crises

      FDA Approvals
      Novartis announced that the European Commission (EC) has approved Adakveo (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or pain crises, in patients...

      Novartis announces collaboration with Molecular Partners to develop two DARPin therapies designed for potential use against COVID-19

      Drug Development
      Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’...

      Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.

      Clinical Trials
      Johnson & Johnson announced today that it is preparing to resume recruitment in the pivotal Phase 3 ENSEMBLE trial of its investigational Janssen COVID-19...

      Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists

      Clinical Trials
      East Lyme, Connecticut, USA: Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.